Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 6
2002 14
2003 14
2004 11
2005 25
2006 18
2007 32
2008 27
2009 25
2010 38
2011 36
2012 37
2013 41
2014 42
2015 26
2016 20
2017 23
2018 28
2019 40
2020 32
2021 29
2022 27
2023 30
2024 28
2025 22
2026 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

579 results

Results by year

Filters applied: . Clear all
Page 1
Uveitis in Children and Adolescents.
Chang MH, Shantha JG, Fondriest JJ, Lo MS, Angeles-Han ST. Chang MH, et al. Rheum Dis Clin North Am. 2021 Nov;47(4):619-641. doi: 10.1016/j.rdc.2021.07.005. Epub 2021 Aug 27. Rheum Dis Clin North Am. 2021. PMID: 34635295 Free PMC article. Review.
Childhood noninfectious uveitis leads to sight-threatening complications. Idiopathic chronic anterior uveitis and juvenile idiopathic arthritis-associated uveitis are most common. ...Children with recurrent, refractory, or severe disease require system …
Childhood noninfectious uveitis leads to sight-threatening complications. Idiopathic chronic anterior uveitis and juven …
Neuro-Behçet's disease: A review.
Belfeki N, Ghriss N, Fourati M, Leclercq D, Saadoun D. Belfeki N, et al. Rev Med Interne. 2024 Oct;45(10):624-633. doi: 10.1016/j.revmed.2024.06.007. Epub 2024 Jun 26. Rev Med Interne. 2024. PMID: 38937151 Review.
Treatment of parenchymatous forms is based on glucocorticoids associated with oral immunosuppressants (azathioprine, mycophenolate mofetil or methotrexate) in mild forms, and intravenous cyclophosphamide or infliximab in severe forms. The management of cerebral thrombosis …
Treatment of parenchymatous forms is based on glucocorticoids associated with oral immunosuppressants (azathioprine, mycophenolate mofetil o …
Uveitis.
Muñoz-Fernández S, Martín-Mola E. Muñoz-Fernández S, et al. Best Pract Res Clin Rheumatol. 2006 Jun;20(3):487-505. doi: 10.1016/j.berh.2006.03.008. Best Pract Res Clin Rheumatol. 2006. PMID: 16777578 Review.
Acute anterior uveitis is the most prevalent form, and it is often associated with spondyloarthritides in which uveitis can be the first manifestation of disease. ...Acute anterior uveitis usually has a good prognosis compared with other forms o …
Acute anterior uveitis is the most prevalent form, and it is often associated with spondyloarthritides in which uveitis …
Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept.
Braun J, Baraliakos X, Listing J, Sieper J. Braun J, et al. Arthritis Rheum. 2005 Aug;52(8):2447-51. doi: 10.1002/art.21197. Arthritis Rheum. 2005. PMID: 16052578 Review.
METHODS: Data from 4 placebo-controlled studies with anti-TNF agents in AS (2 with etanercept and 2 with infliximab) and 3 open-label studies were analyzed for the prestudy prevalence and the incidence of reported flares of anterior uveitis. ...Followup infor …
METHODS: Data from 4 placebo-controlled studies with anti-TNF agents in AS (2 with etanercept and 2 with infliximab) and 3 open-label …
Infliximab versus Cyclophosphamide for Severe Behcet's Syndrome.
Saadoun D, Maalouf G, Vieira M, Trad S, Lazaro E, Sacre K, Plessier A, Sené T, Koné-Paut I, Noel N, Mekinian A, Lambert M, Ribeiro E, Mirault T, Mele N, Dellal A, Fain O, Melki I, Chiche L, Gaudric J, Redheuil A, Maillart E, Ghembaza A, Desbois AC, Mirouse A, Domont F, Leroux G, Ferfar Y, Rigolet A, Viallard JF, Vautier M, Resche-Rigon M, Cacoub P. Saadoun D, et al. NEJM Evid. 2024 Nov;3(11):EVIDoa2300354. doi: 10.1056/EVIDoa2300354. Epub 2024 Oct 22. NEJM Evid. 2024. PMID: 39437137 Clinical Trial.
BACKGROUND: Cyclophosphamide and infliximab are recommended as induction therapies for severe Behcet's syndrome. Whether infliximab is safer and more effective than cyclophosphamide in treating severe Behcet's syndrome is not known. ...Serious adverse events were re …
BACKGROUND: Cyclophosphamide and infliximab are recommended as induction therapies for severe Behcet's syndrome. Whether inflixima …
Enthesitis-related arthritis.
Aggarwal A, Misra DP. Aggarwal A, et al. Clin Rheumatol. 2015 Nov;34(11):1839-46. doi: 10.1007/s10067-015-3029-4. Epub 2015 Aug 2. Clin Rheumatol. 2015. PMID: 26233720 Review.
These children are at risk of developing acute anterior uveitis. A recently devised disease activity index, Juvenile Spondyloarthropathy Disease Activity Index (JSpADA), has been validated in retrospective cohorts. ...
These children are at risk of developing acute anterior uveitis. A recently devised disease activity index, Juvenile Spondyloa …
Infliximab therapy in Behcet's uveitis.
Alizadegan F, Yalcinbayir O, Ucan Gunduz G, Pehlivan Y. Alizadegan F, et al. J Fr Ophtalmol. 2022 Nov;45(9):1036-1041. doi: 10.1016/j.jfo.2022.04.009. Epub 2022 Sep 20. J Fr Ophtalmol. 2022. PMID: 36150991
PURPOSE: To evaluate the efficacy of infliximab (IFX) therapy in patients with Behcet's uveitis (BU) refractory to conventional immunomodulatory treatment (IMT). ...
PURPOSE: To evaluate the efficacy of infliximab (IFX) therapy in patients with Behcet's uveitis (BU) refractory to conventiona …
Management of JIA associated uveitis.
Maccora I, Simonini G, Guly CM, Ramanan AV. Maccora I, et al. Best Pract Res Clin Rheumatol. 2024 Sep;38(3):101979. doi: 10.1016/j.berh.2024.101979. Epub 2024 Jul 23. Best Pract Res Clin Rheumatol. 2024. PMID: 39048481 Review.
Juvenile Idiopathic Arthritis (JIA) is the most common chronic rheumatic disease in childhood, and is associated with uveitis in up to 20-25% of cases. Typically, the uveitis is chronic, asymptomatic, non-granulomatous and anterior. ...If the uveitis r …
Juvenile Idiopathic Arthritis (JIA) is the most common chronic rheumatic disease in childhood, and is associated with uveitis in up t …
New onset of uveitis during infliximab treatment: A case report.
Bouladi M, Ben Othmen A, Sawssen M, Kalou M, Laater A, El Fekih L. Bouladi M, et al. Tunis Med. 2024 Jan 5;102(1):58-60. doi: 10.62438/tunismed.v102i1.4564. Tunis Med. 2024. PMID: 38545732 Free PMC article. Review. English.
We reported a case of new onset of bilateral anterior and intermediate uveitis in a patient with rheumatoid arthritis (RA) while being treated with infliximab and we performed a review of literature. ...We reported a case of new onset of bilateral anterior …
We reported a case of new onset of bilateral anterior and intermediate uveitis in a patient with rheumatoid arthritis (RA) whi …
[Behçet's Syndrome].
Xenitidis T, Henes JC. Xenitidis T, et al. Laryngorhinootologie. 2020 Jun;99(6):377-390. doi: 10.1055/a-1076-9742. Epub 2020 Jun 18. Laryngorhinootologie. 2020. PMID: 32557459 German.
Since 2016, adalimumab has been approved for the treatment of posterior ocular involvement. Infliximab, interferon a2a, interleukin-1 antagonists and apremilast may be alternative therapies....
Since 2016, adalimumab has been approved for the treatment of posterior ocular involvement. Infliximab, interferon a2a, interleukin-1 …
579 results